A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual out-of-pocket spending on prescription drugs to $2,000 for Medicare beneficiaries.

Medicare will begin capping prescription drug costs at $2,000 annually from January 1—a move that's widely expected to benefit millions of Americans.

Billionaire entrepreneur Mark Cuban has been vocal about reshaping the U.S. health care system for years. During recent appearances on podcasts Fishbowl with Jules Terpak and Ground Truths with Dr.

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

A new $2,000 cap on out-of-pocket spending on medications for Medicare Part D beneficiaries goes ... "Research from AARP ...

The bipartisan agreement will fund the government through March. It could also reshape the pharmacy supply chain by reforming ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

This story is part of CBC Health's Second Opinion, a weekly analysis of health and medical science news emailed to subscribers on Saturday mornings. If you haven't subscribed yet, you can do that ...

ICER's analysis revealed that the other five drugs on the list did demonstrate ... acquisition cost increase by 5.9%, with its hike costing U.S. payers $359 million in additional drug spending.

The cost of Leukeran can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Leukeran. As with all ...